Join
Live feed
·
INSIDERFilingvia Quantisnow
Sigilon Therapeutics Inc. logo

SEC Form 4: ANDERSON DANIEL GRIFFITH sold $2,000,000 worth of Common Stock (200,000 units at $10.00), decreasing direct ownership by 9% to 2,022,222 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SGTX (Sigilon Therapeutics Inc.) and more on Quantisnow.